- Open Access
Distinct host cell proteins incorporated by SIV replicating in CD4+T Cells from natural disease resistant versus non-natural disease susceptible hosts
© Stephenson et al; licensee BioMed Central Ltd. 2010
- Received: 30 August 2010
- Accepted: 16 December 2010
- Published: 16 December 2010
Enveloped viruses including the simian immunodeficiency virus (SIV) replicating within host cells acquire host proteins upon egress from the host cells. A number of studies have catalogued such host proteins, and a few have documented the potential positive and negative biological functions of such host proteins. The studies conducted herein utilized proteomic analysis to identify differences in the spectrum of host proteins acquired by a single source of SIV replicating within CD4+ T cells from disease resistant sooty mangabeys and disease susceptible rhesus macaques.
While a total of 202 host derived proteins were present in viral preparations from CD4+ T cells from both species, there were 4 host-derived proteins that consistently and uniquely associated with SIV replicating within CD4+ T cells from rhesus macaques but not sooty mangabeys; and, similarly, 28 host-derived proteins that uniquely associated with SIV replicating within CD4+ T cells from sooty mangabeys, but not rhesus macaques. Of interest was the finding that of the 4 proteins uniquely present in SIV preparations from rhesus macaques was a 26 S protease subunit 7 (MSS1) that was shown to enhance HIV-1 'tat" mediated transactivation. Among the 28 proteins found in SIV preparations from sooty mangabeys included several molecules associated with immune function such as CD2, CD3ε, TLR4, TLR9 and TNFR and a bioactive form of IL-13.
The finding of 4 host proteins that are uniquely associated with SIV replicating within CD4+ T cells from disease susceptible rhesus macaques and 28 host proteins that are uniquely associated with SIV replicating within CD4+ T cells from disease resistant sooty mangabeys provide the foundation for determining the potential role of each of these unique host-derived proteins in contributing to the polarized clinical outcome in these 2 species of nonhuman primates.
- Rhesus Macaque
- Simian Immunodeficiency Virus
- Host Protein
- Viral Copy
- Virus Preparation
The mechanisms by which non-human primate (NHP) natural hosts of the simian immunodeficiency virus (SIV) remain disease resistant, despite plasma viral loads that in some cases far exceed the levels that lead to a spectrum of disease and death (similar to untreated HIV-1 infection of humans leading to AIDS) in non-natural hosts, remain ill defined [1, 2]. Thus while SIV infected sooty mangabeys (SM) and > 40 other African NHP species naturally infected with SIV to a large extent remain disease resistant , select isolates from the natural African hosts, when used to experimentally infect non-natural Asian NHP such as rhesus macaques (RM), invariably lead to disease and death . It has been known for some time that enveloped viruses including HIV-1 and SIV interact with and incorporate a variety of host molecules during the various phases of the life cycle of these viruses within the host cell . Thus, as these virions bud and pinch off the plasma membrane of the host cells, they have been shown to carry with them parts of the plasma membrane containing host proteins some of which remain stably associated with the virions. The role these host proteins play while associated with the virions on the infectivity of the virus and/or on the host immune system remains incompletely understood. These findings prompted us to hypothesize that perhaps differences in the nature of the host proteins that interact with and are incorporated by SIV during its life cycle within cell lineages of the disease resistant SM as compared with disease susceptible RM could contribute to the distinct clinical outcome of SIV infection of these two species.
The pioneering studies aimed at the characterization of host proteins incorporated by lentiviruses were performed by the laboratories of Dr. M Tremblay and highlighted the potentially important role such host proteins can play in the pathogenesis of human HIV-1 infection . The initial studies were focused on identifying the mere physical presence of host proteins that had previously been identified as playing a role in immune function [7, 8]. These studies were soon followed by reports showing that several of these host proteins, such as the MHC class II proteins, ICAM-1, CD28 and CD40L, indeed could enhance the infectivity of the virions, for some as much as 20 to 100-fold with target cells that expressed the cognate receptors for such molecules [9–13]. In addition, the finding of select host encoded cell adhesion molecules (CAMs) within HIV-1 virions further supported the view that the presence of the previously mentioned immunological receptors along with CAMs could facilitate enhanced cell-cell interaction and thus enhance infectivity of the viruses for target cells that expressed receptors for such CAMs [14, 15]. In addition to enhancing viral infectivity, there were also reports of the ability of some of the HIV associated host molecules such as MHC-class II and B7-2 present on both infectious and non-infectious virions to transduce signals that would promote apoptosis of cells bearing receptors for such host proteins [16, 17]. The fact that only 0.01 to 0.00001% of the virions in any given virus preparation are in fact infectious suggests that the biological role of such host proteins within inactive virions may play an important role in inducing immune dysfunction characteristic of lentivirus infections . The first detailed study aimed at cataloging the types of host proteins that become associated with HIV-1 was performed by Chertova et al.  who utilized LC/MS/MS analysis of HIV-1 preparations isolated from infection of enriched populations of human monocyte derived macrophages. A rather substantial list of > 250 host proteins were identified along with 26 of the 37 host proteins previously found to be associated with exosomes.
These findings prompted further studies aimed at defining a) the pathways and the energy barrier being utilized by HIV to bud and egress from cell lineages with the identification of lipid rafts and the virological synapse as being preferentially utilized by HIV-1 [20–22], b) the contribution of microvesicles present in the virus preparations that were being utilized for the analysis of host proteins , c) whether the host proteins non-specifically adhere onto the virus or are incorporated within the virus [8, 24], and d) the use of more sophisticated and ultrasensitive techniques such as LC-MS/MS to detect the presence of such host proteins . A number of other non-proteomic genome-wide association screening (GWAS) assays utilizing RNA silencing techniques have also been utilized to identify the nature of the host proteins that play critical roles in the life cycle of HIV infection, integration, replication and budding [26–28]. These transient RNA silencing techniques using HeLa/293T cell lines has led to the identification of approximately 272, 278 and 304, to a large extent non-overlapping candidate human genes, that play varying roles in the HIV-1 life cycle. The fact that while these cell lines are relatively easy to perform siRNA transfection studies, but are not the most optimal to study HIV-1 infection that primarily targets T cells prompted Yeung et al.  to utilize the JURKAT cell line. These authors capitalized on the availability of a shRNA library that targets 54,509 human targets and prepared a large series of JURKAT cloned T cell lines each containing a discrete shRNA and infected these with HIV-1. Such studies led to the identification of 252 host proteins that were critical for HIV-1 replication . In addition, similar series of cataloging studies led to the establishment of a HIV-1 'tat' human nuclear interactome , and a HIV-1 Human Protein Interaction Database (HHPID) that is readily available at the NCBI website http://www.ncbi.nlm.nih.gov/RefSeq/HIVInteractions and lists a total of 1435 human genes and 2589 unique HIV-1 protein to host cell protein interactions .
The purpose of the studies reported herein was to take advantage of the above findings but focus the studies at the identification of differences in the nature of host proteins incorporated by SIV virions generated by replication within primary CD4+ T cells from disease susceptible RM and disease resistant SM. Data presented herein document the identity of host proteins that are uniquely associated with virions from the 2 species of NHP. The potential role of the proteins identified in contributing to the polarized clinical outcome of SIV infection in the 2 species is discussed.
In efforts to ensure that the identification of the host proteins incorporated by the virions reflected the physiologically "normal" complement of host proteins, we utilized primary cultures of virus infected cells instead of transformed cell lines. Thus, a series of primary day 3 Con-A blasts from 3 individual rhesus macaques (RM) and 3 individual sooty mangabeys (SM) were utilized for infection with a SIVdelTable 670 sub-stock, which replicated well in cells from both species. A single pool of the virus preparation from individual monkeys was purified as outlined in the methods section, and aliquots were subjected to studies detailed below.
Characterization of the virus preparation
Characterization of the pools of virus prepared from primary cultures of CD4+ T cells from rhesus macaques (RM) and sooty mangabeys (SM)
Monkey Species and ID
Levels of p27 (ng/ml)
Viral copy #
x 107 per ml
List of host proteins uniquely found in virus from Rhesus macaques (RM) not Sooty Mangabeys (SM).
Host Proteins in only
26 S protease regulatory subunit 7 (MSS1 protein)
Ubiquitination, HIV transcription
APG7 autophagy 7-like isoform 4
Mitogen-activated protein kinase kinase kinase kinase 1
Tripartite motif-containing 45 isoform 3
List of host proteins uniquely found in virus from Sooty mangabeys but not Rhesus macaques (RM).
Host Proteins in only
2,4-dienoyl CoA reductase 1
40 S ribosomal protein S7 (S8)
Aldo-keto reductase family 1 member C1
CD3e molecule, epsilon (CD3-TCR complex)
immune function associated
Chloride intracellular channel 4 isoform 3
Clathrin, heavy polypeptide-like 1
Cluster of differentiation 2 (CD2)
immune function associated
Collagen, type X, alpha 1 precursor isoform 1
Complement factor I precursor (C3B/C4B inactivator)
immune function associated
Cryptochrome 2 (photolyase-like)
Disulfide-isomerase A3-like protein
immune function associated
Fc receptor-like and mucin-like 2 isoform 3
immune function associated
Filamin B, beta (actin binding protein 278) isoform 3
Gamma-aminobutyric acid (GABA) A receptor, beta 2 isoform 1 isoform 2
Glutamate receptor 1
Guanine nucleotide binding protein-like 3 (nucleolar)-like isoform 2
HBS1-like isoform 3
immune function associated
immune function associated
immune function associated
MAWD binding protein
immune function associated
Programmed cell death protein 6
immune function associated
Quiescin Q6 isoform a
immune function associated
Ribosomal protein L35a
Toll-like receptor 4
immune function associated
Toll-like receptor 9
immune function associated
Transcription elongation factor A (SII)-like 4
Tropomyosin 4 isoform 2
Tumor necrosis factor receptor superfamily, member 17 isoform 1
immune function associated
As stated above, our major goal in the analyses of the host proteins in the viral preparations was to identify those that are consistently differentially expressed by virus preparations from each of the SM but not RM, and each of the RM but not SM. The database was thus analyzed to identify those proteins that were uniquely present in virus preparations from each of the 3 RM, but not SM and vice versa. Surprisingly, such analyses led to the identification of only 4 host proteins uniquely present in virus preparation from each of the 3 RM, but not in any of the virus preparations from the SM. On the other hand 28 proteins were found to be uniquely present in virus preparations from each of the 3 SM but not any of the RM (Tables 2 and 3). The 4 proteins uniquely identified in viral preparations from each of the 3 RM included a 26 S protease regulatory subunit 7 protein. This 26 S protease is involved in the ATP-dependent degradation of ubiquitinated proteins . The regulatory (or ATPase) complex confers ATP dependency and substrate specificity to the 26 S complex. It has been demonstrated that the 26 S protease regulatory subunit 7 (MSS1 protein) enhances the HIV-1 'tat'-mediated transactivation  and associates with basal transcription factors [34, 35] suggesting its role in transcriptional regulation. There is also evidence that the 19 S regulatory complex or its subunits functions as mediators of transcriptional systems through their association with promoters, facilitating the clearance of paused elongation complexes, and recruitment of co-activators [36–40]. A recent study also suggested that the proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms . The second protein identified was APG7, which is an E1 like protein involved in autophagy by facilitating the networking of 2 ubiquitin like proteins APg12 and APg8 to associate with E2 enzymes. The third protein identified was the mitogen protein kinase kinase kinase kinase 1 protein involved in cell signaling. The fourth protein identified was TRIM45, which is part of the Tripartitie motif-containing proteins and is thought to serve as a repressor of mitogen activated protein kinase signaling pathway . Thus, these proteins appear to be either involved in ubiquitination or intracellular signaling, with one of them shown to play an important role in HIV-1 transactivation.
As indicated above, the viral preparations from each of the 3 disease resistant SM contained a 7-times higher number of host proteins that were not identified in viral preparations from the disease susceptible RM. This list of proteins was analyzed for their respective function with a bias to define those that have the potential to be involved directly/indirectly with some aspect of immune function. The analysis led to the identification of 14/28 (50%) proteins being directly and/or indirectly involved in immune function, followed by 5 that were classified as being structural and/or membrane associated proteins, 3 that were nuclear proteins, and 2 each involved in cell metabolism, ribosomal proteins, and neurotransmitter proteins. The "immune function related" virus-associated host cell proteins contained important mediators of T cell signaling. Thus, the CD3ε is part of the T cell receptor (TCR) complex and is the main chain that interacts with the TCR  and the level of its expression shown to be influenced by disease status in HIV-1 infected individuals  resulting in T cell receptor signaling . It is possible that its presence is somehow associated with interference of TCR signaling and thus needs further study. The TNFR superfamily members control diverse aspects of immune function including those mediated by OX40/OX40L interactions. Such interactions regulate CD4+ and CD8+ T cell, NK-T cells, and NK cell function as well as mediating cross talk with antigen presenting cells . The CD2 molecule belongs to the immunoglobulin superfamily of molecules and has been shown to serve as a cell adhesion molecule with LFA-3 (CD58) serving as its ligand . It is expressed by T cells and NK cells and has also been shown to serve a co-stimulatory function . The finding of C3b/C4b inactivator protein is clearly of importance since it is a potent inhibitor of the complement cascade and thus could play a major role in inhibiting the lysis of anti-SIV reactive antibodies. The FcR like and mucin-like protein identified is reminiscent of FcRY, an FcR related gene, which is differentially expressed during B lymphocyte development and activation . The integrin α5 has been shown to be involved in the differentiation of osteoblasts from human bone marrow derived mesenchymal stem cells  and hypothesized to similarly induce the differentiation of the monocytoid lineage of cells. Presumably, its presence within the virus particle may be responsible for the accelerated differentiation of these lineages of hematopoietic cells. Of all the immunologically related proteins identified, the presence of CD2, CD3-ε, IL-13, TLR4, TLR9 and the TNFR proteins were thought to be of great interest. Thus, IL-13 is an immuno-regulatory cytokine, which is secreted primarily by Th2 type of helper T cells, and its major role has been shown to involve allergic diseases and immune responses against a number of parasites [50, 51]. In addition, IL-13 has been shown to play an important role in the biology of intestinal epithelial cells , which are the primary target tissue for both HIV and SIV. Thus, IL-13 has been shown to modulate mucosal epithelial cells by increasing the expression of the pore forming tight junction molecule termed claudin-2 . These findings are of interest in light of the findings of HIV-1 induced dysregulation of claudin-2 in human epithelial cells  and its potential role in promoting bacterial translocation . Thus, the IL-13 present in virus replicating in disease resistant SM could be inducing increased claudin-2 synthesis to rapidly repair the damage induced by SIV in the gut mucosa. The presence of TLR-4 in this regard is also of interest since TLR-4 has been shown to be involved in host defense including its role within the gut tissue by responding to LPS and LPS-like ligands and preventing bacterial translocation , which has been implicated as playing a major role in inducing chronic immune activation characteristic of pathogenic but not apathogenic HIV/SIV infection . TLR-9, like TLR-7, is a receptor that is activated by nucleic acids or CpG containing immuno-stimulatory motifs. Thus, bacterial and viral infections can induce TLR activation with a number of immunological and hematopoietic consequences. These include the release of a number of cytokines and chemokines but also result in protection from apoptosis of plasmacytoid dendritic cells (pDC's). This issue is important since both bacterial and viral infections not only activate TLR's but also result in the synthesis of glucocorticiod hormones (GC), which are immunosuppressive and lead to apoptosis of pDC's. However, ligation of the TLR7/9 by the CpG like motifs results in the upregulation of the anti-apoptotic genes Bcl-2, Bcl-xl, BIRC3 and CFLAR  resulting in survival of the pDC's and preserving the pro-inflammatory pathway leading to protective immune responses. With regards to apoptosis, it is of interest to find the presence of Quiescin 6 in the virions, which is a protein involved in the protection from apoptosis secondary to oxidative stress . The other proteins identified include those that are involved with the gastro-intestinal (GI) tract and include a) disulphide isomerase A3 which has been shown to be a catalytic enzyme that rearranges disulphide bonds in proteins and contribute to immune responses within the GI tract . It has also been shown to be upregulated during alloimmune responses , b) MAWBP which is one of the gastric proteins involved in gastric cancer and its ligand MAWD  which is known to interact with both the TGF-β receptor and Smd 7 resulting in the inhibition of TGF-β signaling . Finally, it is of interest to note the presence of HBS1, which is an intracellular protein involved in mRNA degradation but is also related to translation factors through direct contact with ribosomes and related to Ski7, which is an accessory molecule to exosomes . Exosomes have been implicated as Trojan horses for the pathogenesis of HIV-1 infection [65, 66].
Taken together, the above data indicate that SIV replicating in primary CD4+ T cells from SM appears to incorporate a wide array of host proteins as compared with the same virus replicating in primary CD4+ T cells from RM. Of importance was the finding that while a large number of these host proteins uniquely associated with SIV generated from CD4+ T cells from SM appear to be directly and/or indirectly related to immune function, those few that are uniquely associated with SIV from RM are involved with promoting 'tat' mediated transactivation of HIV-1, autophagy and intracellular signaling. How such proteins contribute to the polarized clinical outcome of infection in these 2 species remains to be defined and is a subject of future studies.
Analysis of host proteins identified in SIV replicating in primary CD4+ T cells from rhesus macaques and sooty mangabeys that have been previously found also to interact with and/or be present in HIV-1 preparations
Type of Analysis
Host cell utilized
Number of host proteins present in SIV/referenced study
Host proteins in HIV-1 preparation
Human primary macrophages
GWAS type of study using shRNA/HIV-1
interacting with HIV-1 tat
Host proteins contributing to productive HIV-1 replication
It is beginning to become clear that a number of these host cellular proteins that become "associated" or "incorporated" by the virus as they exit from the cell can not only influence the biology of the virus (by increasing or decreasing its level of infectivity) but may also function to enhance or suppress immune responses in vivo . While a number of elegant studies have been published on the characterization of host proteins that are associated with HIV-1, the primary purpose of the studies reported herein were focused on determining whether an aliquot of the same virus stock that replicates well and quite similarly within CD4+ T cells from both species included in the present study would differentially acquire host proteins during replication, assembly and egress from cells from disease resistant sooty mangabeys (SM) as compared with the same cell lineage from the disease susceptible rhesus macaques (RM). It should be emphasized that we utilized cultures of primary CD4+ T cells thus eliminating the potential artifacts introduced with the use of transformed cell lines, although the cell lines do provide a larger source of virus and are relatively easy to prepare. As stated above, our studies were designed as such to primarily identify those proteins that are exclusively associated with either pathogenic or apathogenic course of SIV infection, which could lead to an elucidation of some of the pathogenic mechanism underlying SIV disease.
There are several issues that need to be addressed with regards to the studies reported herein, including a) the validation that indeed the proteins identified are truly associated with the virus preparation and not a contaminant, b) whether any of the proteins identified demonstrate function, c) reasons for the marked increases in the number of proteins identified in the SIV prepared from SM versus RM, d) the biological relevance of the proteins identified, and e) the relative sensitivity and specificity of the findings of our studies. These are each addressed below.
One of the most important issues concerning these studies is the biological significance of the findings. Clearly as has been previously described the presence of virus-associated host proteins are of significant consequence as they can serve to a) promote cell to cell transmission of the virus , b) induce NF-κB and NFAT activation , c) the virions can act as antigen presenting cells since they contain both intact MHC class II and CD86  and d) contain a long list of molecules involved in the induction and regulation of immune responses including HLA-Dr, ICAM-1, CD40, CD40L and CD86 . In addition, select molecules present within these viruses also have been implicated in inducing immunosuppression and contributing to innocent bystander apoptosis highlighting the potential important role such host proteins can play in the pathogenesis of HIV/SIV infection. Germane to the present studies, it is important to identify a specific biological role for proteins uniquely found in virus preparations from the RM and the SM in efforts to determine their role in disease susceptibility/resistance. In this regard, it is important to highlight the role of the host protein MSS1 that was found to be uniquely associated with virus preparations from RM, but not SM (Table 2). Thus, the subunit unit 7 of the 26 S proteosome was identified as MSS1 , which was shown to be one of the 'tat' binding proteins (TBP-1)  that regulates HIV-1 transcription by both by a proteolytic and a non-proteolytic mechanism . Interestingly, MSS1 has also been shown to play a critical role in regulating CIITA activity and MHC class II transcription . While preliminary data indicate that the differential incorporation of MSS-1 by virus replicating within CD4+ T cells from RM but not SM could be due to quantitative differences in the constitutive level of MSS-1 present in RM as compared with SM, the reasons for such differential intracellular levels is currently under study. The normal physiological role of the other host proteins identified has been outlined above in the results section but their role in promoting disease resistance requires study. We are cognizant that the disease resistance may not in fact be related to these differentially identified host proteins, but could be due to differences in the response of the host to the proteins that are present in virus preparations from both species and/or due to issues distinct from the presence of host proteins. However, it is a reasonable hypothesis to pursue.
Finally, it is important to address the role of the sensitivity and specificity of the list of proteins that were identified. It should be noted that while there were just 3 viral preparations from each of the 2 species, we chose to utilize highly stringent criteria for inclusion of these proteins with a high scoring threshold and confidence levels of > 97%. Thus, the inclusion of proteins being uniquely present in one species and not the other required for a signature sequence be present in preparations from all 3 monkeys and that there were a minimum of 3 hits for each protein. We submit that these are extremely labor intensive studies and require considerable resources for performing such analyses.
Highly sensitive differential proteomic analysis of SIV preparations from primary CD4+ T cells from 3 sooty mangabeys (the natural disease resistant hosts of SIV) and 3 rhesus macaques (the non-natural disease susceptible hosts) were carried out. These studies led to the identification of 202 host proteins that were found in virus preparations from both rhesus macaques and sooty mangabeys, a total of 28 host proteins that uniquely associated with SIV from each of the 3 sooty mangabeys but none of the rhesus macaques, and 4 host proteins that were uniquely associated with SIV from each of the 3 rhesus macaques but none of the sooty mangabeys. The finding of host proteins such as MSS1 that enhances HIV-1 'tat" mediated transactivation unique to SIV from rhesus macaques and a series of molecules associated with immune function such as IL-13 found in SIV from sooty mangabeys provides a reasonable foundation to initiate studies on the potential link of these unique proteins to the polarized clinical outcome of SIV infection in these 2 nonhuman primate species.
Peripheral blood samples were obtained from 3 normal healthy adult rhesus macaques (Macaca mulatta) denoted as RM and 3 SIV naïve sooty mangabeys (Cercocebus atys) denoted as SM. All monkeys were maintained at the Yerkes National Primate Research Center of Emory University according to the guidelines of the Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council and the Health and Human Services guidelines "Guide for the Care and Use of Laboratory Animals."
Isolation and in vitro infection of PBMCs
PBMCs were isolated from freshly obtained heparinized peripheral blood by standard gradient centrifugation using Lymphoprep lymphocyte separation medium (AXIS-SHIELD PoC AS, Oslo, Norway). The cells were first depleted of CD8+ T cells using Dynabeads-CD8 (Invitrogen, Carlsbad, CA) and maintained in vitro in RPMI 1640 media supplemented with 10% FBS, 2 mM L-glutamine, 50 μg/ml gentamicin and 50 U/ml IL-2 at a density of 2 × 106 cells/ml.
These in vitro cultured cells were activated by co-culture with 2 μg/ml Con-A for 72 hours, then washed and transferred to 50 ml conical tubes and spin inoculated with SIVdelTable 670 at 1200 × g for 2 hours at room temperature. The pelleted cells were washed 2× in PBS to remove residual virus and then cultured at of 2 × 106 cells/ml in RPMI 1640 media supplemented as above. Culture media was removed every other day after 3 days of culture, and supernatants cleared by centrifugation at 3220 × g for 20 minutes. A small aliquot of the cultured cells was monitored daily by trypan blue staining to determine the extent of cell death and cultures were terminated when the level of dead cells exceeded 30%. Levels of p27 were quantified for each supernatant sample using SIV p27 Antigen ELISA (ZeptoMetrix Corporation, Buffalo, New York). Control cultures of CD8+ depleted PBMCs from each monkey were maintained in parallel with the SIV infected samples under identical conditions.
Purification of Virus from Supernatants of Infected Cells
Clarified samples from each of the 3 RM and 3 SM monkeys with the highest p27 levels were ultra-centrifuged and the pelleted virus preparations further purified using the Fast Trap Lentivirus Purification and Concentration Kit (Millipore, Billerica, MA) per manufacturer's instructions. Briefly, clarified supernatants were further filter purified and the sample subsequently bound to an anion exchange membrane. The membrane was washed and the virus eluted using a high salt buffer. The virus was then concentrated and stored in PBS pH 7.4 at -80°C until further use.
Quantitation of p27, the levels of infectivity (TCID50), number of viral copies and protein concentration
Aliquots of each virus preparation were subjected to a) determination of the levels of p27 using the commercial p27 ELISA kit which included a standard that was utilized to calculate the levels of p27 in the specimens, b) analysis of the relative levels of infectious particles using the CEM cell line. The TCID50 of each of the virus preparation was calculated by standard end point titration whereby 2-fold dilutions of the viral preparation were dispensed in triplicates into individual wells containing 105 of the cell line and allowed to incubate for 4 hrs, washed and then cultured in media and the supernatant monitored for levels of p27, c) number of viral copies per ml of the virus preparation using quantitative PCR and a set of gag primer pairs as described elsewhere [75, 76], and d) quantitation of levels of protein using the BioRad protein determination kit (BioRad, Hercules, CA) utilizing the manufacturers protocol. These procedures led to > 100-fold increase in the levels of p27 and number of viral copies adjusted to 1 mg of protein in preparations of the virus prior to and post purification as illustrated in Figure 5A and 5B. Electron microscopic analysis of the virus preparation similarly demonstrated a marked enrichment of viral particles and the depletion of cellular debris (additional file 7).
Protein Identification by Mass Spectrometric Analysis
Protein samples were resolved on a SDS gel and stained by Coomassie blue. Selected gel regions were excised (Figure 1) and subjected to in-gel digestion. The resulting peptides were analyzed by reverse-phase liquid chromatography coupled with tandem mass spectrometry  using an LTQ-Orbitrap mass spectrometer (Thermo Finnigan, San Jose, CA). The databases searched were derived from ftp://ftp.ncbi.nih.gov/refseq/release/vertebrate_mammalian/of the NCBI Refseq project and utilized available primate, rhesus macaque, sooty mangabey and SIV viral protein sequences. A strategy of reverse database analysis was used to evaluate false discovery rate; the matched peptides were filtered according to matching scores to remove all false matches from the reverse database . This is a highly stringent filter system employed to make sure that the proteins being identified were in fact present in the viral preparation. Thus only proteins that were matched by at least a set of peptides unique to the specific protein in a single virus preparation were selected for addition to the resulting virus-host protein database. Results were analyzed using Microsoft Access.
Samples (30 μg of protein per sample) were separated on SDS-PAGE using a 4-20% gradient ReadyGel (Bio-Rad), transferred to nitrocellulose membrane (BioRad) and the membrane blocked with 5% non-fat milk in T-TBS prior to incubation with the indicated antibody overnight. After being washed 3 times with T-TBS, the membrane was incubated with the appropriate secondary antibody conjugated to HRP for 1 hour at room temperature. All bands were visualized using the ECL detection system (Amersham Biosciences). Equal loading of the samples was determined using anti-β actin antibodies with each analysis (Sigma). The series of IL-13 monoclonal antibodies were a generous gift from Dr. N. Ahlborg of the MabTech corporation (Nacka Strand, Sweden) and the clone showing the highest reactivity (clone IL-13-3) against recombinant rhesus IL-13 was used at a concentration of 1:1000 in T-TBS containing 5% BSA. Bands for IL-13 were visualized using anti-rat IgG conjugated to HRP (Southern Biotech, Birmingham, AL). Anti-TLR4 and TLR9 antibodies were purchased from Abcam (Cambridge, MA) and bands visualized using anti-goat and anti-mouse IgG conjugated to HRP (Southern Biotech, Birmingham, AL), respectively.
The IL-4 and IL-13 dependent B9 cell line was utilized to determine the presence of biologically active IL-13 in aliquots of the same viral preparations as were used for proteomic analyses. The B9 cell line was starved off cytokines overnight, washed and 100,000 cells in a volume of 50 μl of media were then dispensed into individual wells of a 96-well microtiter plate. Varying concentrations of recombinant human IL-13 was added to triplicate wells in efforts to derive a standard curve to be utilized for the quantitation of the level of potential IL-13 that was present in the viral preparation. The viral preparation from RM and SM were adjusted to 5 μg/ml protein concentration and diluted 2-fold in media and each dilution added in a volume of 50 μl of media to triplicate wells in the presence/absence of 50 μl of a 1/10 dilution of neutralizing anti-IL13 monoclonal antibody (known to neutralize 100 ng/ml of recombinant IL-13). The plates were incubated for 48 hrs in a 7% CO2 humidified atmosphere and 16 hrs prior to harvest each well was labeled with 1 μCi of methyl-3H-thymidine and the mean uptake of 3H-thymidine determined. The lower limit of this assay was determined to be 5 pg/ml.
The ability of the MSS-1 protein to enhance HIV-1 'tat' mediated transactivation was utilized by our laboratory in efforts to initiate studies on the differential role of this protein in cells from RM and SM. Briefly, the MSS-1 was first cloned into an expression plasmid and used in conjunction with a HIV-1 'tat' expression plasmid to transfect the standard TZM-bl cells. The amount of HIV-1 'tat' plasmid to be used in the assay was first titrated and the level that showed low levels of β-galactosidase activity (0.2 ug of plasmid) chosen. The TZM-bl cells were seeded in 96-well plates (5000 cell per well) and transfected with 0.2 ug of the HIV-1 'tat' expression plasmid, 0.8 μg of the MSS1 expression plasmid, or both using the Lipofectamine 2000 reagent (Invitrogen). At 48 h post-transfection, β-galactosidase activity was determined using the Tropix Gal-Screen assay kit (Applied Biosystems, Carsbad, CA).
These studies were supported by NIH-RO1-AI065362, NIH-RO1-AI078773, Yerkes Base grant NIH-DRR -00165 and Grant Agency of the Czech Republic grant number P304-10-1161.
The authors are grateful to Dr. E. Chertova for her generosity in sharing her data files with us, to Dr. Jeff Lifson for his numerous attempts to derive a CD4+ CCR5+ T cell line from SM, Dr. N. Ahlborg of Mabtech for his generous gift of the IL-13 reagents, Dr. Guanghui Wang (University of Science and Technology, China) for derivation of the MSS-1 plasmid and to Dr. Junmin Peng and the staff of the Emory Proteomics Core Service Center who performed the proteomics work, especially Dr. Duc Duong for working with us on the database selection and answering our questions graciously. We are also indebted to the Ms. Stephanie Ehnert and her outstanding staff at the Yerkes National Primate Center for all their hard work in taking care of the animals and performing all the procedures on the animals that were utilized in the studies reported herein.
- Ansari AA, Onlamoon N, Bostik P, Mayne AE, Gargano L, Pattanapanyasat K: Lessons learnt from studies of the immune characterization of naturally SIV infected sooty mangabeys. Front Biosci. 2003, 8: s1030-1050. 10.2741/1180.View ArticlePubMedGoogle Scholar
- Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, Else JG, Estes JD, Hahn BH, Hirsch VM, Kaur A, Kirchhoff F, Muller-Trutwin M, Pandrea I, Schmitz JE, Silvestri G: Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med. 2009, 15: 861-865. 10.1038/nm.2013.PubMed CentralView ArticlePubMedGoogle Scholar
- VandeWoude S, Apetrei C: Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev. 2006, 19: 728-762. 10.1128/CMR.00009-06.PubMed CentralView ArticlePubMedGoogle Scholar
- McClure HM, Anderson DC, Fultz PN, Ansari AA, Lockwood E, Brodie A: Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. Vet Immunol Immunopathol. 1989, 21: 13-24. 10.1016/0165-2427(89)90126-8.View ArticlePubMedGoogle Scholar
- Cantin R, Methot S, Tremblay MJ: Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol. 2005, 79: 6577-6587. 10.1128/JVI.79.11.6577-6587.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Tremblay MJ, Fortin JF, Cantin R: The acquisition of host-encoded proteins by nascent HIV-1. Immunol Today. 1998, 19: 346-351. 10.1016/S0167-5699(98)01286-9.View ArticlePubMedGoogle Scholar
- Ott DE: Cellular proteins in HIV virions. Rev Med Virol. 1997, 7: 167-180. 10.1002/(SICI)1099-1654(199709)7:3<167::AID-RMV199>3.0.CO;2-K.View ArticlePubMedGoogle Scholar
- Ott DE: Potential roles of cellular proteins in HIV-1. Rev Med Virol. 2002, 12: 359-374. 10.1002/rmv.367.View ArticlePubMedGoogle Scholar
- Cantin R, Fortin JF, Lamontagne G, Tremblay M: The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J Virol. 1997, 71: 1922-1930.PubMed CentralPubMedGoogle Scholar
- Fortin JF, Barbeau B, Hedman H, Lundgren E, Tremblay MJ: Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology. 1999, 257: 228-238. 10.1006/viro.1999.9687.View ArticlePubMedGoogle Scholar
- Fortin JF, Cantin R, Tremblay MJ: T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol. 1998, 72: 2105-2112.PubMed CentralPubMedGoogle Scholar
- Giguere JF, Paquette JS, Bounou S, Cantin R, Tremblay MJ: New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1. J Immunol. 2002, 169: 2762-2771.View ArticlePubMedGoogle Scholar
- Martin G, Tremblay MJ: HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. Clin Immunol. 2004, 111: 275-285. 10.1016/j.clim.2004.02.004.View ArticlePubMedGoogle Scholar
- Guo MM, Hildreth JE: HIV acquires functional adhesion receptors from host cells. AIDS Res Hum Retroviruses. 1995, 11: 1007-1013. 10.1089/aid.1995.11.1007.View ArticlePubMedGoogle Scholar
- Orentas RJ, Hildreth JE: Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses. 1993, 9: 1157-1165. 10.1089/aid.1993.9.1157.View ArticlePubMedGoogle Scholar
- Bounou S, Dumais N, Tremblay MJ: Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J Biol Chem. 2001, 276: 6359-6369. 10.1074/jbc.M002198200.View ArticlePubMedGoogle Scholar
- Esser MT, Graham DR, Coren LV, Trubey CM, Bess JW, Arthur LO, Ott DE, Lifson JD: Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. J Virol. 2001, 75: 6173-6182. 10.1128/JVI.75.13.6173-6182.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993, 259: 1749-1754. 10.1126/science.8096089.View ArticlePubMedGoogle Scholar
- Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, Bess JW, Sowder RC, Barsov E, Hood BL, Fisher RJ, Nagashima K, Conrads TP, Veenstra TD, Lifson JD, Ott DE: Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol. 2006, 80: 9039-9052. 10.1128/JVI.01013-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Gladnikoff M, Shimoni E, Gov NS, Rousso I: Retroviral assembly and budding occur through an actin-driven mechanism. Biophys J. 2009, 97: 2419-2428. 10.1016/j.bpj.2009.08.016.PubMed CentralView ArticlePubMedGoogle Scholar
- Morita E, Sundquist WI: Retrovirus budding. Annu Rev Cell Dev Biol. 2004, 20: 395-425. 10.1146/annurev.cellbio.20.010403.102350.View ArticlePubMedGoogle Scholar
- Nguyen DH, Hildreth JE: Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol. 2000, 74: 3264-3272. 10.1128/JVI.74.7.3264-3272.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Trubey CM, Chertova E, Coren LV, Hilburn JM, Hixson CV, Nagashima K, Lifson JD, Ott DE: Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles. J Virol. 2003, 77: 12699-12709. 10.1128/JVI.77.23.12699-12709.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Ott DE, Coren LV, Johnson DG, Kane BP, Sowder RC, Kim YD, Fisher RJ, Zhou XZ, Lu KP, Henderson LE: Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology. 2000, 266: 42-51. 10.1006/viro.1999.0075.View ArticlePubMedGoogle Scholar
- Saphire AC, Gallay PA, Bark SJ: Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J Proteome Res. 2006, 5: 530-538. 10.1021/pr050276b.View ArticlePubMedGoogle Scholar
- Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ: Identification of host proteins required for HIV infection through a functional genomic screen. Science. 2008, 319: 921-926. 10.1126/science.1152725.View ArticlePubMedGoogle Scholar
- Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK: Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell. 2008, 135: 49-60. 10.1016/j.cell.2008.07.032.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS: Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe. 2008, 4: 495-504. 10.1016/j.chom.2008.10.004.View ArticlePubMedGoogle Scholar
- Yeung ML, Houzet L, Yedavalli VS, Jeang KT: A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem. 2009, 284: 19463-19473. 10.1074/jbc.M109.010033.PubMed CentralView ArticlePubMedGoogle Scholar
- Gautier VW, Gu L, O'Donoghue N, Pennington S, Sheehy N, Hall WW: In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology. 2009, 6: 47-10.1186/1742-4690-6-47.PubMed CentralView ArticlePubMedGoogle Scholar
- Pinney JW, Dickerson JE, Fu W, Sanders-Beer BE, Ptak RG, Robertson DL: HIV-host interactions: a map of viral perturbation of the host system. AIDS. 2009, 23: 549-554.PubMedGoogle Scholar
- Pickart CM, Cohen RE: Proteasomes and their kin: proteases in the machine age. Nat Rev Mol Cell Biol. 2004, 5: 177-187. 10.1038/nrm1336.View ArticlePubMedGoogle Scholar
- Shibuya H, Irie K, Ninomiya-Tsuji J, Goebl M, Taniguchi T, Matsumoto K: New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature. 1992, 357: 700-702. 10.1038/357700a0.View ArticlePubMedGoogle Scholar
- Makino Y, Yogosawa S, Kayukawa K, Coin F, Egly JM, Wang Z, Roeder RG, Yamamoto K, Muramatsu M, Tamura T: TATA-Binding protein-interacting protein 120, TIP120, stimulates three classes of eukaryotic transcription via a unique mechanism. Mol Cell Biol. 1999, 19: 7951-7960.PubMed CentralView ArticlePubMedGoogle Scholar
- Yanagi S, Shimbara N, Tamura T: Tissue and cell distribution of a mammalian proteasomal ATPase, MSS1, and its complex formation with the basal transcription factors. Biochem Biophys Res Commun. 2000, 279: 568-573. 10.1006/bbrc.2000.3969.View ArticlePubMedGoogle Scholar
- Bhat KP, Turner JD, Myers SE, Cape AD, Ting JP, Greer SF: The 19 S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription. Mol Immunol. 2008, 45: 2214-2224. 10.1016/j.molimm.2007.12.001.View ArticlePubMedGoogle Scholar
- Ferdous A, Gonzalez F, Sun L, Kodadek T, Johnston SA: The 19 S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol Cell. 2001, 7: 981-991. 10.1016/S1097-2765(01)00250-7.View ArticlePubMedGoogle Scholar
- Ferdous A, Kodadek T, Johnston SA: A nonproteolytic function of the 19 S regulatory subunit of the 26 S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry. 2002, 41: 12798-12805. 10.1021/bi020425t.View ArticlePubMedGoogle Scholar
- Gonzalez F, Delahodde A, Kodadek T, Johnston SA: Recruitment of a 19 S proteasome subcomplex to an activated promoter. Science. 2002, 296: 548-550. 10.1126/science.1069490.View ArticlePubMedGoogle Scholar
- Lassot I, Latreille D, Rousset E, Sourisseau M, Linares LK, Chable-Bessia C, Coux O, Benkirane M, Kiernan RE: The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol Cell. 2007, 25: 369-383. 10.1016/j.molcel.2006.12.020.View ArticlePubMedGoogle Scholar
- Wang Y, Li Y, Qi X, Yuan W, Ai J, Zhu C, Cao L, Yang H, Liu F, Wu X, Liu M: TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. Biochem Biophys Res Commun. 2004, 323: 9-16. 10.1016/j.bbrc.2004.08.048.View ArticlePubMedGoogle Scholar
- Dave VP: Hierarchical role of CD3 chains in thymocyte development. Immunol Rev. 2009, 232: 22-33. 10.1111/j.1600-065X.2009.00835.x.View ArticlePubMedGoogle Scholar
- Wu JQ, Wang B, Belov L, Chrisp J, Learmont J, Dyer WB, Zaunders J, Cunningham AL, Dwyer DE, Saksena NK: Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages. Retrovirology. 2007, 4: 83-10.1186/1742-4690-4-83.PubMed CentralView ArticlePubMedGoogle Scholar
- Gorman CL, Monaco C, Ammiratti E, Vermi AC, Marelli-Berg FM, Cope AP: Tracking antigen-experienced effector T cells in vitro and in vivo. Methods Mol Biol. 2010, 616: 253-267. full_text.View ArticlePubMedGoogle Scholar
- Croft M: Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol. 2010, 28: 57-78. 10.1146/annurev-immunol-030409-101243.PubMed CentralView ArticlePubMedGoogle Scholar
- Kaizuka Y, Douglass AD, Vardhana S, Dustin ML, Vale RD: The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells. J Cell Biol. 2009, 185: 521-534. 10.1083/jcb.200809136.PubMed CentralView ArticlePubMedGoogle Scholar
- Umehara H, Huang JY, Kono T, Tabassam FH, Okazaki T, Gouda S, Nagano Y, Bloom ET, Domae N: Co-stimulation of T cells with CD2 augments TCR-CD3-mediated activation of protein tyrosine kinase p72syk, resulting in increased tyrosine phosphorylation of adapter proteins, Shc and Cbl. Int Immunol. 1998, 10: 833-845. 10.1093/intimm/10.6.833.View ArticlePubMedGoogle Scholar
- Masuda K, Davis RS, Maruyama T, Zhang J, He T, Cooper MD, J OW, Burrows PD: FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activation. Gene. 2005, 363: 32-40. 10.1016/j.gene.2005.08.016.View ArticlePubMedGoogle Scholar
- Hamidouche Z, Fromigue O, Ringe J, Haupl T, Marie PJ: Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol. 2010, 11: 44-10.1186/1471-2121-11-44.PubMed CentralView ArticlePubMedGoogle Scholar
- Brightling CE, Saha S, Hollins F: Interleukin-13: prospects for new treatments. Clin Exp Allergy. 2010, 40: 42-49.PubMed CentralPubMedGoogle Scholar
- Hopkin J: Immune and genetic aspects of asthma, allergy and parasitic worm infections: evolutionary links. Parasite Immunol. 2009, 31: 267-273. 10.1111/j.1365-3024.2009.01104.x.View ArticlePubMedGoogle Scholar
- Mandal D, Fu P, Levine AD: REDOX regulation of IL-13 signaling in intestinal epithelial cells: usage of alternate pathways mediates distinct gene expression patterns. Cell Signal. 2010, 22: 1485-1494. 10.1016/j.cellsig.2010.05.017.PubMed CentralView ArticlePubMedGoogle Scholar
- Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD: Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005, 129: 550-564.View ArticlePubMedGoogle Scholar
- Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, Kaushic C: Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010, 6: e1000852-10.1371/journal.ppat.1000852.PubMed CentralView ArticlePubMedGoogle Scholar
- Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006, 12: 1365-1371. 10.1038/nm1511.View ArticlePubMedGoogle Scholar
- Chen LW, Chang WJ, Chen PH, Hsu CM: Commensal microflora induce host defense and decrease bacterial translocation in burn mice through toll-like receptor 4. J Biomed Sci. 2010, 17: 48-10.1186/1423-0127-17-48.PubMed CentralView ArticlePubMedGoogle Scholar
- Brenchley JM, Silvestri G, Douek DC: Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity. 2010, 32: 737-742. 10.1016/j.immuni.2010.06.004.PubMed CentralView ArticlePubMedGoogle Scholar
- Lepelletier Y, Zollinger R, Ghirelli C, Raynaud F, Hadj-Slimane R, Cappuccio A, Hermine O, Liu YJ, Soumelis V: Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid pre-dendritic cells (pDC). Blood. 2010,Google Scholar
- Morel C, Adami P, Musard JF, Duval D, Radom J, Jouvenot M: Involvement of sulfhydryl oxidase QSOX1 in the protection of cells against oxidative stress-induced apoptosis. Exp Cell Res. 2007, 313: 3971-3982. 10.1016/j.yexcr.2007.09.003.View ArticlePubMedGoogle Scholar
- Ding Y, Lu B, Chen D, Meng L, Shen Y, Chen S: Proteomic analysis of colonic mucosa in a rat model of irritable bowel syndrome. Proteomics. 2010Google Scholar
- Kienzl K, Sarg B, Golderer G, Obrist P, Werner ER, Werner-Felmayer G, Lindner H, Maglione M, Schneeberger S, Margreiter R, Brandacher G: Proteomic profiling of acute cardiac allograft rejection. Transplantation. 2009, 88: 553-560. 10.1097/TP.0b013e3181b119b1.View ArticlePubMedGoogle Scholar
- Zhang J, Kang B, Tan X, Bai Z, Liang Y, Xing R, Shao J, Xu N, Wang R, Liu S, Lu Y: Comparative analysis of the protein profiles from primary gastric tumors and their adjacent regions: MAWBP could be a new protein candidate involved in gastric cancer. J Proteome Res. 2007, 6: 4423-4432. 10.1021/pr0703425.View ArticlePubMedGoogle Scholar
- Datta PK, Moses HL: STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol Cell Biol. 2000, 20: 3157-3167. 10.1128/MCB.20.9.3157-3167.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Tollervey D: Molecular biology: RNA lost in translation. Nature. 2006, 440: 425-426. 10.1038/440425a.View ArticlePubMedGoogle Scholar
- Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ: Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol. 2006, 172: 923-935. 10.1083/jcb.200508014.PubMed CentralView ArticlePubMedGoogle Scholar
- Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, Blanco J, Borras FE, Puertas MC, Connor JH, Fernandez-Figueras MT, et al: Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood. 2009, 113: 2732-2741. 10.1182/blood-2008-05-158642.PubMed CentralView ArticlePubMedGoogle Scholar
- van Dijk D, Ertaylan G, Boucher CA, Sloot PM: Identifying potential survival strategies of HIV-1 through virus-host protein interaction networks. BMC Syst Biol. 2010, 4: 96-10.1186/1752-0509-4-96.PubMed CentralView ArticlePubMedGoogle Scholar
- Kolegraff K, Bostik P, Ansari AA: Characterization and role of lentivirus-associated host proteins. Exp Biol Med (Maywood). 2006, 231: 252-263.Google Scholar
- Raghavendra NK, Shkriabai N, Graham R, Hess S, Kvaratskhelia M, Wu L: Identification of host proteins associated with HIV-1 preintegration complexes isolated from infected CD4+ cells. Retrovirology. 2010, 7: 66-10.1186/1742-4690-7-66.PubMed CentralView ArticlePubMedGoogle Scholar
- Esser MT, Bess JW, Suryanarayana K, Chertova E, Marti D, Carrington M, Arthur LO, Lifson JD: Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J Virol. 2001, 75: 1152-1164. 10.1128/JVI.75.3.1152-1164.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Bostik P, Mayne AE, Villinger F, Greenberg KP, Powell JD, Ansari AA: Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys. J Immunol. 2001, 166: 506-516.View ArticlePubMedGoogle Scholar
- Pandrea I, Apetrei C, Gordon S, Barbercheck J, Dufour J, Bohm R, Sumpter B, Roques P, Marx PA, Hirsch VM, Kaur A, Lackner AA, Veazey RS, Silvestri G: Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood. 2007, 109: 1069-1076. 10.1182/blood-2006-05-024364.PubMed CentralView ArticlePubMedGoogle Scholar
- Roy J, Martin G, Giguere JF, Belanger D, Petrin M, Tremblay MJ: HIV type 1 can act as an APC upon acquisition from the host cell of peptide-loaded HLA-DR and CD86 molecules. J Immunol. 2005, 174: 4779-4788.View ArticlePubMedGoogle Scholar
- Dubiel W, Ferrell K, Rechsteiner M: Peptide sequencing identifies MSS1, a modulator of HIV Tat-mediated transactivation, as subunit 7 of the 26 S protease. FEBS Lett. 1993, 323: 276-278. 10.1016/0014-5793(93)81356-5.View ArticlePubMedGoogle Scholar
- Mori K, Yasutomi Y, Sawada S, Villinger F, Sugama K, Rosenwith B, Heeney JL, Uberla K, Yamazaki S, Ansari AA, Rubsamen-Waigmann H: Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection. J Virol. 2000, 74: 5747-5753. 10.1128/JVI.74.13.5747-5753.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Villinger F, Brice GT, Mayne AE, Bostik P, Mori K, June CH, Ansari AA: Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. Blood. 2002, 99: 590-599. 10.1182/blood.V99.2.590.View ArticlePubMedGoogle Scholar
- Peng J, Gygi SP: Proteomics: the move to mixtures. J Mass Spectrom. 2001, 36: 1083-1091. 10.1002/jms.229.View ArticlePubMedGoogle Scholar
- Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP: Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res. 2003, 2: 43-50. 10.1021/pr025556v.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.